By Django Gold ( November 20, 2012, 4:57 PM EST) -- Merck & Co. Inc. on Tuesday renewed its challenge to a Third Circuit ruling holding "pay-for-delay" pharmaceutical patent settlements as presumptively anti-competitive, telling the U.S. Supreme Court that it should take up both that case and a separate Eleventh Circuit ruling in order to resolve the matter....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.